Search

Several types of cancer were once strongly linked to an AIDS diagnosis. Thanks to improved HIV medications, that's changing.

… Wednesday, April 3, 2019 Summary People with HIV are sometimes susceptible to getting specific types of cancer. This association has changed over the years, as drugs to control HIV infection have become available. When the AIDS epidemic began in 1981, many of the first reported cases were young gay men

A drug combination that halts tumor cell division can stir the immune system into taking action.

… Thursday, December 20, 2018 Summary According to scientists at the Sloan Kettering Institute, a two-drug combination that doesn’t directly kill tumor cells can still help as a cancer treatment. The key is activating the immune system. The goal of most cancer-fighting drugs is to kill tumor cells. But

In what is being hailed as a watershed moment for both cancer care and biotechnology, the US Food and Drug Administration has approved a personalized, cell-based immunotherapy for use in children and young adults with blood cancer. For more information or to arrange interviews, e-mail Caitlin Hool at [email protected].

… Tuesday, September 5, 2017 The FDA has approved a new type of immunotherapy called chimeric antigen receptor (CAR) T cell therapy . In this approach, scientists genetically engineer a patient’s own immune cells to make a new protein that can latch onto cancer. This turns them into supercharged cancer

Our findings indicate that surgical site infections can be reduced effectively over the long term with a hospital-wide implementation of multidisciplinary best practices.

… Thursday, December 13, 2018 Implementation of a multidisciplinary care bundle composed of 13 perioperative components has significantly decreased the rate of surgical site infections (SSIs) among patients undergoing colorectal cancer surgery at Memorial Sloan Kettering Cancer Center, according to our

The Specialized Programs of Research Excellence (SPORE) grant will fund efforts focusing on the development of new treatments.

… Tuesday, September 7, 2021 Memorial Sloan Kettering Cancer Center has received a major grant from the US National Institutes of Health (NIH) to conduct research related to leukemia . It is the sixth grant of this type to be received by MSK investigators. It is referred to as a SPORE grant, for Specialized

Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS, has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK).

… Thursday, July 12, 2018 Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS , has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician and leader, Dr. Gerstle most recently served as Director of

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.

… Thursday, May 19, 2016 https://www.youtube.com/watch?v=lrB1gjztQSk The immunotherapy drug nivolumab is giving hope to Hodgkin lymphoma patients like Ariella after standard treatments don’t work. Video courtesy Cancer Research Institute. Summary Patients with Hodgkin lymphoma whose disease returns after

Chief of the Melanoma Service Michael Postow, MD, Medical Oncologist Nitya Raj, MD, and Assistant Attending Triparna Sen, PhD were included on this year’s list.

… Thursday, October 15, 2020 Memorial Sloan Kettering (MSK) is proud to announce that Chief of the Melanoma Service https://www.mskcc.org/cancer-care/doctors/michael-postow Michael Postow, MD , Medical Oncologist  Nitya Raj, MD , and Assistant Attending Triparna Sen, PhD, are included in the 40 Under 40

New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.

… Monday, October 26, 2020 Summary MSK investigators uncover new findings about the relationship between clonal hematopoiesis in cancer patients and the risk of later developing a treatment-related blood cancer. In recent years, improvements in cancer therapy have led to a significant increase in cancer

Read advice from an MSK clinical psychologist about how caregivers of people with cancer can best manage their emotions and life responsibilities.

… Tuesday, February 27, 2024 For family caregivers, one of the major stresses is  advance care planning  — the process of talking about and documenting goals for future healthcare. Since 2012, the Counseling Center at Memorial Sloan Kettering Cancer Center (MSK) has provided individual and family support